2005
DOI: 10.1097/00001199-200507000-00010
|View full text |Cite
|
Sign up to set email alerts
|

A Review of the Effectiveness of Antioxidant Therapy to Reduce Neuronal Damage in Acute Traumatic Brain Injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 14 publications
0
16
0
Order By: Relevance
“…Thus, the relationship between oxidative stress and TBI has generated considerable interest in the development of antioxidant therapies for neuroprotection. However, despite promising results in the treatment of TBI in animal models, evidence of successful antioxidant therapy in TBI patients is limited [7] . In addition, there are a number of drawbacks to the use of exogenous antioxidants for treatment, as many antioxidants do not efficiently cross the bloodbrain barrier (BBB), are rather unstable in the body, have short therapeutic time windows, and should be given in a very narrow range of therapeutic dosages owing to their toxicity at high doses [7,8] .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, the relationship between oxidative stress and TBI has generated considerable interest in the development of antioxidant therapies for neuroprotection. However, despite promising results in the treatment of TBI in animal models, evidence of successful antioxidant therapy in TBI patients is limited [7] . In addition, there are a number of drawbacks to the use of exogenous antioxidants for treatment, as many antioxidants do not efficiently cross the bloodbrain barrier (BBB), are rather unstable in the body, have short therapeutic time windows, and should be given in a very narrow range of therapeutic dosages owing to their toxicity at high doses [7,8] .…”
Section: Introductionmentioning
confidence: 99%
“…However, despite promising results in the treatment of TBI in animal models, evidence of successful antioxidant therapy in TBI patients is limited [7] . In addition, there are a number of drawbacks to the use of exogenous antioxidants for treatment, as many antioxidants do not efficiently cross the bloodbrain barrier (BBB), are rather unstable in the body, have short therapeutic time windows, and should be given in a very narrow range of therapeutic dosages owing to their toxicity at high doses [7,8] . Hence, alternative therapeutic approaches are needed to inhibit the detrimental effects of ROS, for instance, through the induction of endogenous enzymatic antioxidants.…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, these findings have not directly translated to the clinical situation [125,126]. Unfortunately, these findings have not directly translated to the clinical situation [125,126].…”
Section: Antioxidant Therapy For Traumatic Brain Injurymentioning
confidence: 99%
“…Despite the promising results in the treatment of TBI in animal models, evidence of successful antioxidant therapy in clinical practice is limited [143]. There are a number of drawbacks to the use of exogenous antioxidants, for example, the limited penetrability through the BBB, the rapid metabolism and instability of these compounds, short therapeutic windows, and a very narrow therapeutic dosage range, resulting in toxicity at higher doses [143, 144]. Despite these limitations, natural antioxidants and modified antioxidants are promising candidates for future drugs to treat TBI.…”
Section: Antioxidant Strategies For Neuroprotectionmentioning
confidence: 99%